The Takiwasi Center has a library specialized in traditional medicines, which holds a fund of more than 4,900 books, 2,000 articles and 300 audio-visual elements mainly related to the fields of ethnomedicine, indigenous spirituality, psychology, anthropology, drug addictions and botany. It is a unique resource for the domestic and foreign researchers who have free access to it. Takiwasi's resident patients also benefit from its contents.
Takiwasi also has a collection of digital documents which includes a wide variety of books and articles related to medicinal plants, spirituality and psychology topics, among others. These contents, accessible through our website, are organized according to three classification groups: Articles produced by Takiwasi, Documents of general interest and Theses and research works carried out by domestic and foreign students and researchers.
The Center also develops its own editorial line that has several magazines, documentaries and books that are available for sale in our Store, whether in physical or digital format.
Authors: Ilana Berlowitz, Heinrich Walt, Christian Ghasarian, Fernando Mendive, Chantal Martin-Soelch
Published in Journal of Psychoactive Drugs, May 2019.
Chronic illness management today commonly involves alternative medicines. Substance use disorder (SUD), as a chronic psychosomatic illness, might benefit from a similar approach. The accredited Takiwasi Center offers such an SUD treatment program involving Amazonian medicine combined with psychotherapy. The current study assessed this integrative program‘s short-term therapeutic effects. We measured baseline data from 53 dependence-diagnosed males admitted to treatment (T1) and repeated clinical outcome variables at treatment completion (T2). Paired samples t-tests were used to assess changes between T1 and T2 (n = 36). Nearly all participants (age M= 30.86, SD= 8.17) were dependent on multiple substances, most prominently cannabis, alcohol, and cocaine-related drugs. A significant decrease (T1 to T2) was found for addiction severity outcomes drug use (p < .001), alcohol use (p < .001), psychiatric status (p < .001), and social/familial relationships (p < .001). Emotional distress also diminished significantly (p < .001), as did substance craving (p < .001). Quality of life increased significantly from T1 to T2 (p < .001). Our results provide first indications for significantly improved SUD symptoms after the Amazonian medicine-based treatment. These findings are preliminary given the design, but strongly encourage further investigation of this therapy, which in the long term may open new therapeutic avenues for SUDs.
Further documents of interest can be found on the following websites: